The critical role of IL-12 and the IL-12Rβ2 subunit in the generation of pathogenic autoreactive Th1 cells

被引:44
作者
Shevach, EM
Chang, JT
Segal, BM
机构
[1] NIH, Immunol Lab, NIAID, Bethesda, MD 20892 USA
[2] Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA
来源
SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1999年 / 21卷 / 03期
关键词
D O I
10.1007/s002810050066
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Experimental Allergic Encephalomyelitis (EAE) is a demyelinating disease of the central nervous system which is an animal model for the human autoimmune disease, multiple sclerosis. EAE is mediated by CD4(+) T cells and the T cells responsible for disease induction produce Th1 cytokines. IL-12 produced by monocytes and dendritic cells is the most critical factor which influences the development and differentiation of pathogenic autoreactive Th1 cells. Here, we review our recent studies on the critical contributions of IL-12 and the IL-12R beta 2 subunit to the generation of autoreactive effector cells which mediate EAE. In addition, we discuss the potential contribution of IL-18 to the upregulation of the IL-12/IL-12R beta 2 pathway and the contribution of the suppressor cytokines, IL-4 and IL-10, in downregulating this pathway. Collectively, our studies demonstrate that the IL-12/IL-12R beta 2 pathway is a critical intermediary in the process of Th1 differentiation which can be both positively or negatively regulated. This pathway remains an attractive immunotherapeutic target for blockade of function with inhibitory reagents or downregulation by Th2 cytokines.
引用
收藏
页码:249 / 262
页数:14
相关论文
共 51 条
[41]  
SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125
[42]   DEVELOPMENTAL COMMITMENT TO THE TH2 LINEAGE BY EXTINCTION OF IL-12 SIGNALING [J].
SZABO, SJ ;
JACOBSON, NG ;
DIGHE, AS ;
GUBLER, U ;
MURPHY, KM .
IMMUNITY, 1995, 2 (06) :665-675
[43]   Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells [J].
Szabo, SJ ;
Dighe, AS ;
Gubler, U ;
Murphy, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :817-824
[44]  
Tremeau A., 1995, Traitement du Signal, V12, P1
[45]  
TRIPP CS, 1994, J IMMUNOL, V152, P1883
[46]  
Willenborg DO, 1996, J IMMUNOL, V157, P3223
[47]  
WRAITH DC, 1992, J IMMUNOL, V149, P3765
[48]   ANTIGEN RECOGNITION IN AUTOIMMUNE ENCEPHALOMYELITIS AND THE POTENTIAL FOR PEPTIDE-MEDIATED IMMUNOTHERAPY [J].
WRAITH, DC ;
SMILEK, DE ;
MITCHELL, DJ ;
STEINMAN, L ;
MCDEVITT, HO .
CELL, 1989, 59 (02) :247-255
[49]   Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells [J].
Xu, DM ;
Chan, WL ;
Leung, BP ;
Hunter, D ;
Schulz, K ;
Carter, RW ;
McInnes, IB ;
Robinson, JH ;
Liew, FY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1485-1492
[50]  
Yoshimoto T, 1998, J IMMUNOL, V161, P3400